Table 2. The incidence of anemia during treatment and comparison by clinical characteristics.
| Anemia during 1st line anti-cancer treatment | |||
|---|---|---|---|
| Overall frequency | 129/345 (37.4%) | ||
| Morphologic features of anemia (n = 129) | Microcytic anemia Normocytic anemia Macrocytic anemia |
1 (0.8%) 124 (96.1%) 4 (3.1%) |
|
| Comparison by clinical characteristics | Anemia, number (%) | p-value | |
| Age | <60 ≥60 |
56 (31.8) 73 (43.2) |
0.029 |
| Gender | male female |
77 (35.6) 52 (40.3) |
0.387 |
| Cancer sites | Gastric cancer Colorectal cancer Hepatocellular carcinoma Lung cancer |
40 (39.6) 15 (21.7) 6 (26.1) 68 (44.7) |
0.007 |
| Stage | Non-metastatic disease Metastatic disease |
67 (35.1) 62 (40.3) |
0.323 |
| Treatment | Chemotherapy Chemo-radiation Target agents |
81 (37.7) 33 (44.0) 15 (27.3) |
0.060 |